Navigation Links
Drs Sandy Chang and Kathleen Collins Join LIFE LENGTH®'s Scientific Advisory Board

MADRID, March 6, 2012 /PRNewswire/ --

Life Length, the world's leading telomere testing and services company, announced that Drs Sandy Chang and Kathleen Collins have joined its Scientific Advisory Board ("SAB").

Stephen J. Matlin, CEO, Life Length, noted, "We are delighted to welcome these world-renowned telomere and telomerase experts to Life Length's SAB. They will help advance our global leadership.  Dr Chang is especially well known for pioneering work in understanding how telomere binding proteins protect chromosome ends from engaging DNA damage response.  Dr. Collins has led the way in reconstituting recombinant telomerase complexes and demonstrating the significance of individual differences in telomere length on human health span."

Dr Sandy Chang is currently Associate Professor and Associate Director of Molecular Diagnostics, Department of Laboratory Medicine, Yale University School of Medicine, having received numerous awards including those from the Howard Hughes Medical Institute, the Ellison Medical Foundation, the Sidney Kimmel Foundation for Cancer Research, and the Ellis Benson Award from the Academy of Clinical Laboratory Physicians and Scientists.

Dr Kathleen Collins is Professor of Molecular and Cell Biology at the University of California, Berkeley.  Her awards include a Burroughs Wellcome Fund Award in Pharmacological Sciences, Early Career Life Scientist Award from The American Society for Cell Biology, and University of California Berkeley Miller Professorship.

In addition to Drs Chang and Collins, the Life Length SAB includes Dr María A. Blasco, Director, Spanish National Cancer Research Centre; Dr Jerry W. Shay, Vice Chairman, Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas; Dr William H. Andrews, founder, President and CEO, Sierra Sciences, that focuses exclusively on finding drugs that will transiently induce expression of endogenous telomerase in human cells; and Dr Mark Rosenberg, MD, President, The Institute for Healthy Aging.

About Life Length

Life Length, a life sciences company founded in 2010 to commercially exploit Telomere Analysis Technology (TAT) as a spin-off of the Spanish National Cancer Research Centre, is the only company in world able to individually measure critically short telomeres, the crucial measure for cell senescence, aging and age-related diseases. Life Length provides testing services to pharmaceutical and biotech industries for drug R&D and clinical trials, as well as to the general public through physicians and clinics interested in telomere indicators of biological age and overall health.

SOURCE Life Length
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award
2. Media Alert: Elekta to Present $50,000 to Miami-Based Sandy B. Muller Breast Cancer Foundation at ASTRO Annual Meeting
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Getty Images Celebrates Conclusion of Change Me Imagery Forum
5. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
6. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
7. Micromet Announces Changes in Management Team
8. Cancer Cure Coalition Proposes Major Changes at the FDA
9. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
10. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
11. Silence Therapeutics Announces Board Changes
Post Your Comments:
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel ... the company will present at the LD Micro Main Event. ... Sunset Boulevard Hotel in Los Angeles, CA. ... present on Thursday, December 3, at 9:00 am Pacific time ... at least 10 minutes prior to the start of the ...
(Date:12/1/2015)... Dec. 1, 2015   MabVax Therapeutics Holdings, Inc ... announces it has filed an Investigational New Drug Application ... for the Company,s lead fully human antibody product HuMab ... MabVax plans to initiate the Phase I clinical trial ... --> The planned Phase I trial will ...
(Date:12/1/2015)... 2015   Craneware, Inc ., the healthcare ... announced the company will showcase a new version ... solution at the American Society for Health-System ... The new features are focused on simplifying and ... managing enterprise-wide pharmacy charges to ensure compliance and ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds are ... are well aware that psychology-based patient non-compliance (disobedience of a health care provider’s ... diseases of the diabetic foot. The American Board of Multiple Specialties in ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
Breaking Medicine News(10 mins):